A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia

Tumor microenvironment (TME) has been revealed as an important determinant of diagnosis and treatment response in AML patients. The scores of immune and stromal cell scores of AML in the intermediate-risk group from The Cancer Genome Atlas (TCGA) database were calculated using the Estimation of STro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Cong, Hu, Dong, Zheng, Jin'e, Cao, Shiyi, Zhu, Jiang, Chen, Xiangjun, Huang, Shiang, Yao, Junxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076319/
https://www.ncbi.nlm.nih.gov/pubmed/35528167
http://dx.doi.org/10.1155/2022/4010786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076319/
https://www.ncbi.nlm.nih.gov/pubmed/35528167
http://dx.doi.org/10.1155/2022/4010786

Ejemplares similares